Oral Tramadol for the Treatment of Pain of 7–30 Days’ Duration in Children
- 1 January 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 96 (1), 78-81
- https://doi.org/10.1097/00000539-200301000-00016
Abstract
This open-label, multicenter trial was designed to determine the safety profile and analgesic efficacy of tramadol for the treatment of painful conditions lasting 7-30 days in 7-16-yr-old children. We found that tramadol 1-2 mg/kg per os every 4-6 h (maximal dose = 8 mg x kg(-1). d(-1), not to exceed 400 mg/d) is a safe and effective analgesic in this patient population.This publication has 12 references indexed in Scilit:
- Caudal bupivacaine‐tramadol combination for postoperative analgesia in pediatric herniorrhaphyActa Anaesthesiologica Scandinavica, 2001
- Analgesic efficacy of tramadol 2 mg kg−1 for paediatric day-case adenoidectomyBritish Journal of Anaesthesia, 2001
- Pharmacokinetics of tramadol in children after i.v. or caudal epidural administrationBritish Journal of Anaesthesia, 2000
- Oral tramadol: analgesic efficacy in children following multiple dental extractionsEuropean Journal of Anaesthesiology, 1999
- Caudal tramadol for postoperative analgesia in pediatric hypospadias surgery.British Journal of Anaesthesia, 1997
- Tramadol: A new centrally acting analgesicAmerican Journal of Health-System Pharmacy, 1997
- Tolérance et sécurité dʼemploi du tramadolDrugs, 1997
- The Pharmacology of TramadolDrugs, 1994
- Efficacy and Safety of Tramadol Versus Morphine for Moderate and Severe Postoperative Pain With Special Regard to Respiratory DepressionAnesthesia & Analgesia, 1992
- Tramadol: pain relief by an opioid without depression of respirationAnaesthesia, 1992